Skip to content

Study to Evaluate Efficacy, Safety and Injection Technique of Restylane Lip Volume and Restylane Lip Refresh

An Open, Multi-center Study Evaluating Efficacy, Safety and Injection Technique of Restylane Lip Products for Lip Enhancement and Lip Rejuvenation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01428024
Enrollment
60
Registered
2011-09-02
Start date
2011-09-30
Completion date
2012-06-30
Last updated
2022-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Injection Techniques

Keywords

efficacy, safety, Restylane, Lip products, injection techniques

Brief summary

The purpose of this study is to demonstrate the efficacy and safety of two new Restylane Lip products, Restylane Lip Volume and Restylane Lip Refresh, and to collect information on the injection technique.

Detailed description

Restylane Lip Volume is intended to be used for lip enhancement and Restylane Lip Refresh is intended to restore hydrobalance and improve skin structure of the lips (referred to as lip rejuvenation in this protocol), respectively. The lidocaine content is designed to reduce the subject's pain during treatment. The objectives of this open, multicenter study are to evaluate efficacy and safety of the products for the studied indications and to collect information on injection techniques used.

Interventions

DEVICERestylane Lip Volume

Treatment of up to 1,5 ml product for upper and lower lip, respectively at week 0 and optional at week 12.

DEVICERestylane Lip Refresh

Treatment of up to 0,5 ml product for upper and lower lip, respectively at week 0 and optional at week 12.

Sponsors

Galderma R&D
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* 18 to 60 years of age. * Intent to undergo lip augmentation or rejuvenation of both the upper and lower lip. * Signed informed consent.

Exclusion criteria

* Prior surgery or tattoo to the upper or lower lip or lip line. * Presence of any abnormal lip structure, such as a scar or lump or severe lip asymmetry. * A history of herpes labialis and an outbreak within four weeks of study entry or with four or more outbreaks in the 12 months prior to study entry. * Presence of facial hair that may interfere with efficacy evaluations. * Active skin disease, inflammation or related conditions, such as infection, psoriasis and herpes zoster near or on the area to be treated. * History of angioedema. * Previous hypersensitivity to hyaluronic acid or local anesthetics. * Concomitant anticoagulant therapy and therapy with inhibitors of platelet aggregation within 10 days prior to treatment, or a history of bleeding disorders. * Cancerous or pre-cancerous lesions in the area to be treated. * Previous tissue augmenting therapy in the area to be treated with hyaluronic acid (HA) or collagen filler, or laser treatment, during the last 12 months. * Permanent implant placed in the area to be treated or treatment with non-HA or non-collagen filler in the area to be treated. * Pregnancy or breast feeding. * Participation in any other clinical study within 30 days prior to inclusion. * Other condition preventing the subject to entering the study in the Investigator's opinion e.g. subjects not likely to avoid other facial cosmetic treatments below the level of the lower orbital rim, subjects anticipated to be unreliable or incapable of understanding the study assessment or unrealistic expectations of treatment result. * Study staff or close relative to study staff (e.g. parents, children, siblings or spouse).

Design outcomes

Primary

MeasureTime frameDescription
GEIS (Global Esthetic Improvement Scale) Assessed by the Subject at Week 8 After TreatmentAt week 8 - change of lips from baselineTo evaluate esthetic change of lips from baseline as judged by the subjects using GEIS. GEIS is a categorical scale with five levels: very much improved, much improved, somewhat improved, no change, worse.

Secondary

MeasureTime frameDescription
GEIS (Global Esthetic Improvement Scale) Assessed by the Treating Investigator at Week 36 After Treatmentweek 36 - change from baselineTo evaluate esthetic change of lips from baseline as judged by the treating investigator using GEIS at week 36. GEIS is a categorical scale with five levels: very much improved, much improved, somewhat improved, no change.
GEIS (Global Esthetic Improvement Scale) Assessed by the Independent Evaluator at Week 36 After Treatmentweek 36 - change from baselineTo evaluate esthetic change of lips from baseline as judged by the independent evaluator using GEIS at week 2, 4, 12, 26 and 36. GEIS is a categorical scale with five levels: very much improved, much improved, somewhat improved, no change, worse.
GEIS (Global Esthetic Improvement Scale) Assessed by the Subject at Week 36 After Treatmentweek 36 - change from baselineTo evaluate esthetic change of lips from baseline as judged by the subjects using GEIS at week 36. GEIS is a categorical scale with five levels: very much improved, much improved, somewhat improved, no change, worse.
Subject Satisfaction QuestionnaireWeek 8To evaluate subjects satisfaction in terms of a subject satisfaction questionnaire at week 8 after treatment. The subject satisfaction questionnaire consists of questions regarding the looks, appearance, disomfort, and satisfaction regarding the treatment of the lips. The question that will be referred to is: How satisfied are you today with (the look of) your lips ?
Subject Diary for 14 Days After Initial Treatment2 weeks after initial treatmentTo evaluate the acute safety profile (bruising, itching, pain, redness, swelling and tenderness) in terms of a 14-day subject diary after initial treatment. Subjects still reporting one or more of the symptoms; bruising, itching, pain, redness, swelling and tenderness in the diary at day 14.
MLFS (Medicis Lip Fullness Scale) at Week 8week 8 - change from baselineTo evaluate the efficacy in terms of Medicis Lip Fullness Scale (MLFS) score by live assessment performed separately by the treating and the independent investigators in the Restylane Lip Volume group. The scale has five levels: Very thin, thin, median, full, very full. Treatment success is defined as at least one grade increase.

Countries

Sweden

Participant flow

Participants by arm

ArmCount
Restylane LipVolume
Open label Restylane Lip Volume : Treatment of up to 1,5 ml product for upper and lower lip, respectively at week 0 and week 12.
30
Restylane Lip Refresh
Open label Restylane Lip Refresh : Treatment of up to 0,5 ml product for upper and lower lip, respectively at week 0 and week 12.
30
Total60

Baseline characteristics

CharacteristicRestylane Lip RefreshRestylane LipVolumeTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
30 Participants30 Participants60 Participants
Age, Continuous49.4 years
STANDARD_DEVIATION 6.4
36.1 years
STANDARD_DEVIATION 12.5
42.8 years
STANDARD_DEVIATION 11.9
Region of Enrollment
Sweden
30 participants30 participants60 participants
Sex: Female, Male
Female
30 Participants30 Participants60 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
16 / 3021 / 30
serious
Total, serious adverse events
3 / 300 / 30

Outcome results

Primary

GEIS (Global Esthetic Improvement Scale) Assessed by the Subject at Week 8 After Treatment

To evaluate esthetic change of lips from baseline as judged by the subjects using GEIS. GEIS is a categorical scale with five levels: very much improved, much improved, somewhat improved, no change, worse.

Time frame: At week 8 - change of lips from baseline

Population: One subject did not perform GEIS evaluation at the 8-week visit and withdrew consent after the visit

ArmMeasureValue (NUMBER)
Restylane Lip VolumeGEIS (Global Esthetic Improvement Scale) Assessed by the Subject at Week 8 After Treatment86.2 percentage improved subjects
Restylane Lip RefreshGEIS (Global Esthetic Improvement Scale) Assessed by the Subject at Week 8 After Treatment86.7 percentage improved subjects
Secondary

GEIS (Global Esthetic Improvement Scale) Assessed by the Independent Evaluator at Week 36 After Treatment

To evaluate esthetic change of lips from baseline as judged by the independent evaluator using GEIS at week 2, 4, 12, 26 and 36. GEIS is a categorical scale with five levels: very much improved, much improved, somewhat improved, no change, worse.

Time frame: week 36 - change from baseline

ArmMeasureValue (NUMBER)
Restylane Lip VolumeGEIS (Global Esthetic Improvement Scale) Assessed by the Independent Evaluator at Week 36 After Treatment86.2 percentage improved subjects
Restylane Lip RefreshGEIS (Global Esthetic Improvement Scale) Assessed by the Independent Evaluator at Week 36 After Treatment86.2 percentage improved subjects
Secondary

GEIS (Global Esthetic Improvement Scale) Assessed by the Subject at Week 36 After Treatment

To evaluate esthetic change of lips from baseline as judged by the subjects using GEIS at week 36. GEIS is a categorical scale with five levels: very much improved, much improved, somewhat improved, no change, worse.

Time frame: week 36 - change from baseline

Population: Restylane Lip Volume: One subject withdrew consent after the 8-week visit and thus did not perform the GEIS evaluation at 36 weeks.~Restylane Lip Refresh: Two subjects did not perform the GEIS evaluation at 36 weeks.

ArmMeasureValue (NUMBER)
Restylane Lip VolumeGEIS (Global Esthetic Improvement Scale) Assessed by the Subject at Week 36 After Treatment93.1 percentage improved subjects
Restylane Lip RefreshGEIS (Global Esthetic Improvement Scale) Assessed by the Subject at Week 36 After Treatment78.6 percentage improved subjects
Secondary

GEIS (Global Esthetic Improvement Scale) Assessed by the Treating Investigator at Week 36 After Treatment

To evaluate esthetic change of lips from baseline as judged by the treating investigator using GEIS at week 36. GEIS is a categorical scale with five levels: very much improved, much improved, somewhat improved, no change.

Time frame: week 36 - change from baseline

ArmMeasureValue (NUMBER)
Restylane Lip VolumeGEIS (Global Esthetic Improvement Scale) Assessed by the Treating Investigator at Week 36 After Treatment82.8 percentage improved subjects
Restylane Lip RefreshGEIS (Global Esthetic Improvement Scale) Assessed by the Treating Investigator at Week 36 After Treatment82.8 percentage improved subjects
Secondary

MLFS (Medicis Lip Fullness Scale) at Week 8

To evaluate the efficacy in terms of Medicis Lip Fullness Scale (MLFS) score by live assessment performed separately by the treating and the independent investigators in the Restylane Lip Volume group. The scale has five levels: Very thin, thin, median, full, very full. Treatment success is defined as at least one grade increase.

Time frame: week 8 - change from baseline

ArmMeasureValue (NUMBER)
Restylane Lip VolumeMLFS (Medicis Lip Fullness Scale) at Week 850.0 percentage improved subjects
Secondary

Subject Diary for 14 Days After Initial Treatment

To evaluate the acute safety profile (bruising, itching, pain, redness, swelling and tenderness) in terms of a 14-day subject diary after initial treatment. Subjects still reporting one or more of the symptoms; bruising, itching, pain, redness, swelling and tenderness in the diary at day 14.

Time frame: 2 weeks after initial treatment

ArmMeasureValue (NUMBER)
Restylane Lip VolumeSubject Diary for 14 Days After Initial Treatment2 participants
Restylane Lip RefreshSubject Diary for 14 Days After Initial Treatment6 participants
Secondary

Subject Satisfaction Questionnaire

To evaluate subjects satisfaction in terms of a subject satisfaction questionnaire at week 8 after treatment. The subject satisfaction questionnaire consists of questions regarding the looks, appearance, disomfort, and satisfaction regarding the treatment of the lips. The question that will be referred to is: How satisfied are you today with (the look of) your lips ?

Time frame: Week 8

ArmMeasureValue (NUMBER)
Restylane Lip VolumeSubject Satisfaction Questionnaire93 percentage satisfied subjects
Restylane Lip RefreshSubject Satisfaction Questionnaire87 percentage satisfied subjects

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026